An integrated genotyping approach for HLA and other complex genetic systems

Area of Science:

• Clinical immunogenetics
• Molecular diagnostics
• Genomic technologies

Background:

• Clinical laboratories seek to adopt next-generation sequencing (NGS) for human leukocyte antigen (HLA) testing due to potential cost savings, accuracy, and flexibility.
• Existing NGS workflows often lack comprehensive sample preparation and data analysis solutions for clinical settings.
• The adoption of NGS in clinical immunogenetics is hindered by the need for integrated systems.

Purpose of the Study:

• To develop and validate an Integrated Genotyping System (IGS) for clinical NGS-based HLA and KIR typing.
• To address the challenges of implementing NGS technology in routine clinical laboratory workflows.
• To demonstrate the system's capability across various DNA sample types and genetic loci.

Main Methods:

• Development of the Integrated Genotyping System (IGS) for amplicon sequencing.
• Testing of 336 DNA specimens from whole blood, dried blood spots, buccal swabs, and lymphoblastoid cell lines.
• Parallel human leukocyte antigen (HLA) class I and II genotyping and KIR haplotyping using the IGS.

Main Results:

• The Integrated Genotyping System (IGS) was successfully developed and tested for HLA genotyping.
• The system demonstrated accuracy and flexibility across diverse DNA sources.
• KIR haplotyping was performed in parallel, showcasing the extensibility of the IGS workflow.

Conclusions:

• The Integrated Genotyping System (IGS) provides a comprehensive solution for clinical NGS-based human leukocyte antigen (HLA) and KIR genotyping.
• The validated system facilitates the adoption of NGS technology in clinical immunogenetics laboratories.
• This advancement holds potential for improving diagnostic accuracy and advancing precision medicine through enhanced genetic analysis.